Insider: Crockett Thomas Andrew CEO - KalVista Pharmaceuticals, Inc.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 211,203 | 0 | 211,203 |
| Value | $2,618,917.20 | $0.00 | $2,618,917.20 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/20/2024 | DDS | 24,888 | Direct | COM | $14.11 | $351,289.14 | 211,203 |
| 02/14/2024 | DDS | 58,356 | Direct | COM | $15.01 | $875,882.71 | 181,676 |
| 02/01/2024 | DDS | 9,300 | Direct | COM | $16.18 | $150,428.43 | 118,232 |
| 02/01/2024 | DDS | 700 | Direct | COM | $16.81 | $11,770.01 | 117,532 |
| 12/27/2023 | DDS | 30,000 | Direct | COM | $12.02 | $360,453.00 | 127,532 |
| 11/20/2023 | DDS | 14,807 | Direct | COM | $8.23 | $121,851.25 | 157,532 |
| 08/18/2023 | DDS | 14,876 | Direct | COM | $10.73 | $159,601.63 | 146,756 |
| 05/18/2023 | DDS | 5,627 | Direct | COM | $10.14 | $57,082.54 | 128,050 |
| 11/18/2022 | DDS | 1,785 | Direct | COM | $5.44 | $9,710.40 | 114,878 |
| 09/02/2022 | DDS | 1,320 | Direct | COM | $17.01 | $22,457.69 | 110,858 |
| 08/17/2022 | DDS | 1,797 | Direct | COM | $14.96 | $26,890.49 | 112,178 |
| 03/09/2022 | DDS | 10,000 | Direct | COM | $17.07 | $170,693.00 | 114,670 |
| 10/01/2021 | DDS | 10,000 | Direct | COM | $17.18 | $171,841.00 | 124,670 |
| 07/01/2021 | DDS | 4,350 | Direct | COM | $23.88 | $103,872.35 | 140,320 |
| 07/01/2021 | DDS | 5,650 | Direct | COM | $24.35 | $137,604.62 | 134,670 |
| 06/17/2021 | DDS | 1,067 | Direct | COM | $30.04 | $32,050.55 | 144,670 |
| 06/09/2021 | DDS | 8,933 | Direct | COM | $30.05 | $268,480.42 | 145,737 |
| 04/01/2021 | DDS | 800 | Direct | COM | $28.11 | $22,490.00 | 159,420 |
| 04/01/2021 | DDS | 700 | Direct | COM | $26.22 | $18,356.03 | 168,720 |
| 04/01/2021 | DDS | 8,500 | Direct | COM | $27.48 | $233,590.20 | 160,220 |
| 02/23/2021 | DDS | 7,218 | Direct | COM | $33.73 | $243,429.94 | 171,702 |
| 02/23/2021 | DDS | 500 | Direct | COM | $35.40 | $17,700.00 | 178,920 |
| 02/23/2021 | DDS | 1,575 | Direct | COM | $32.94 | $51,877.35 | 170,127 |
| 02/23/2021 | DDS | 707 | Direct | COM | $31.87 | $22,531.03 | 169,420 |
| 01/04/2021 | DDS | 9,186 | Direct | COM | $18.13 | $166,557.80 | 186,234 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research